Financial News
|
Fund Overview
Quote
Performance
|
Chart
Charting
Compare to:
|
Top News
More News
Big Biotech ETF Can Bounce Back
April 18, 2018
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund by assets, and other biotechnology assets have recently been slumping, but some analysts believe big... Read More
from ETF Trends
Best & Worst Weekly Performers: April 14 Edition
April 14, 2018
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
LABU: ETF Inflow Alert
April 11, 2018
Symbols mentioned in this story: LABU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded... Read More
from ETF Channel
LABU Makes Bullish Cross Above Critical Moving Average
April 10, 2018
In trading on Tuesday, shares of the Daily S&P Biotech Bull 3X Shares ETF (LABU) crossed above their 200 day moving average of $78.85, changing hands as high as $79.59 per share. Daily S&P Biotech Bull... Read More
from ETF Channel
Catalysts Abound for Biotech ETFs
April 10, 2018
Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR S&P Biotech ETF (NYSEArca: XBI) came into Monday with a loss of almost 12.6% over the... Read More
from ETF Trends
Best & Worst Weekly Performers: April 7 Edition
April 07, 2018
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Best & Worst Weekly Performers: March 31 Edition
March 31, 2018
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
For Now, Traders Endorse Biotech Rally
March 28, 2018
Among leveraged and inverse biotechnology exchange-traded funds, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) and the ... Read More
from Benzinga
Betting Big on Biotech ETFs? Traders Leverage ETFs
March 28, 2018
With biotechnology stocks and ETFs expected to remain areas of interest throughout 2018, risk-tolerant traders may want to consider examining leveraged ETFs as short times on the biotechnology space.... Read More
from ETF Trends
Buy on the Dip Prospects: March 26 Edition
March 26, 2018
Below is a look at ETFs that currently offer attractive buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in... Read More
from ETFdb
Best & Worst Weekly Performers: March 24 Edition
March 24, 2018
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as... Read More
from ETFdb
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
